| Literature DB >> 15294162 |
Enrico Patrucco1, Antonella Notte, Laura Barberis, Giulio Selvetella, Angelo Maffei, Mara Brancaccio, Stefano Marengo, Giovanni Russo, Ornella Azzolino, Sergei D Rybalkin, Lorenzo Silengo, Fiorella Altruda, Reinhard Wetzker, Matthias P Wymann, Giuseppe Lembo, Emilio Hirsch.
Abstract
The G protein-coupled, receptor-activated phosphoinositide 3-kinase gamma (PI3Kgamma) mediates inflammatory responses and negatively controls cardiac contractility by reducing cAMP concentration. Here, we report that mice carrying a targeted mutation in the PI3Kgamma gene causing loss of kinase activity (PI3KgammaKD/KD) display reduced inflammatory reactions but no alterations in cardiac contractility. We show that, in PI3KgammaKD/KD hearts, cAMP levels are normal and that PI3Kgamma-deficient mice but not PI3KgammaKD/KD mice develop dramatic myocardial damage after chronic pressure overload induced by transverse aortic constriction (TAC). Finally, our data indicate that PI3Kgamma is an essential component of a complex controlling PDE3B phosphodiesterase-mediated cAMP destruction. Thus, cardiac PI3Kgamma participates in two distinct signaling pathways: a kinase-dependent activity that controls PKB/Akt as well as MAPK phosphorylation and contributes to TAC-induced cardiac remodeling, and a kinase-independent activity that relies on protein interactions to regulate PDE3B activity and negatively modulates cardiac contractility.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15294162 DOI: 10.1016/j.cell.2004.07.017
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582